Vacuna Dermatophagoides mezcla Placebo, Vacuna Dermatophagoides mezcla 3000 TBU/ml, Test de provocación nasal, Vacuna Dermatophagoides mezcla 6000 TBU/ml, Vacuna Dermatophagoides mezcla 1000 TBU/ml
APISLIT-DD-D-2025-01
Phase 2 small_molecule active
Quick answer
Vacuna Dermatophagoides mezcla Placebo, Vacuna Dermatophagoides mezcla 3000 TBU/ml, Test de provocación nasal, Vacuna Dermatophagoides mezcla 6000 TBU/ml, Vacuna Dermatophagoides mezcla 1000 TBU/ml for Allergic rhinitis/rhinoconjunctivitis caused by dust mite allergy is a Phase 2 program (small_molecule) at Advanced Accelerator Applications with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Advanced Accelerator Applications
- Indication
- Allergic rhinitis/rhinoconjunctivitis caused by dust mite allergy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active